Wednesday, 8 August 2012

Chronic Obstructive Pulmonary Disease-Food And Drug Administration-Aclidinium Bromide

Tudorza Pressair Approved for COPD

TUESDAY, July 24 (Healthday News) -- The Tudorza Pressair (aclidinium bromide) inhaler has been approved by the U.S. Food and Drug Administration to treat narrowing of the lung airways associated with chronic obstructive pulmonary disease (COPD) in people 18 and older. read more..

No comments:

Post a Comment